These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33712706)

  • 1. Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors.
    Chiang CJ; Huang PH
    Sci Rep; 2021 Mar; 11(1):5853. PubMed ID: 33712706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy.
    Chiang CJ; Hong YH
    Sci Rep; 2021 Sep; 11(1):18172. PubMed ID: 34518590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice.
    Loessner H; Leschner S; Endmann A; Westphal K; Wolf K; Kochruebe K; Miloud T; Altenbuchner J; Weiss S
    Microbes Infect; 2009 Dec; 11(14-15):1097-105. PubMed ID: 19665575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy.
    Li R; Helbig L; Fu J; Bian X; Herrmann J; Baumann M; Stewart AF; Müller R; Li A; Zips D; Zhang Y
    Res Microbiol; 2019 Mar; 170(2):74-79. PubMed ID: 30447257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a new T7 promoter compatible Escherichia coli Nissle 1917 strain for recombinant production of heme-dependent proteins.
    Fiege K; Frankenberg-Dinkel N
    Microb Cell Fact; 2020 Oct; 19(1):190. PubMed ID: 33023596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice.
    Stritzker J; Hill PJ; Gentschev I; Szalay AA
    Bioeng Bugs; 2010; 1(2):139-45. PubMed ID: 21326939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice.
    Stritzker J; Weibel S; Hill PJ; Oelschlaeger TA; Goebel W; Szalay AA
    Int J Med Microbiol; 2007 Jun; 297(3):151-62. PubMed ID: 17448724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
    Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
    Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering.
    Hu S; Fei M; Fu B; Yu M; Yuan P; Tang B; Yang H; Sun D
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2277-2288. PubMed ID: 36929190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins.
    Seo EJ; Weibel S; Wehkamp J; Oelschlaeger TA
    Int J Med Microbiol; 2012 Nov; 302(6):276-87. PubMed ID: 22748509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system.
    Pöhlmann C; Thomas M; Förster S; Brandt M; Hartmann M; Bleich A; Gunzer F
    Bioengineered; 2013; 4(3):172-9. PubMed ID: 23111320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate SlyA and H-NS nucleoprotein complexes control hlyE expression in Escherichia coli K-12.
    Lithgow JK; Haider F; Roberts IS; Green J
    Mol Microbiol; 2007 Nov; 66(3):685-98. PubMed ID: 17892462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.
    Schultz M; Watzl S; Oelschlaeger TA; Rath HC; Göttl C; Lehn N; Schölmerich J; Linde HJ
    J Microbiol Methods; 2005 Jun; 61(3):389-98. PubMed ID: 15767015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering the probiotic bacterium Escherichia coli Nissle 1917 as an efficient cell factory for heparosan biosynthesis.
    Hu S; Zhao L; Hu L; Xi X; Zhang Y; Wang Y; Chen J; Chen J; Kang Z
    Enzyme Microb Technol; 2022 Aug; 158():110038. PubMed ID: 35453037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression.
    Wu D; Zhao Z; Liu H; Fu K; Ji Y; Ji W; Li Y; Yan Q; Yang G
    Acta Biomater; 2023 Oct; 169():477-488. PubMed ID: 37532134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Genome-Scale Metabolic Model and Phenome Analysis of the Probiotic
    Kim D; Kim Y; Yoon SH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672760
    [No Abstract]   [Full Text] [Related]  

  • 17. Production and Sensing of Butyrate in a Probiotic
    Bai Y; Mansell TJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443851
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang Y; Ji W; He L; Chen Y; Ding X; Sun Y; Hu S; Yang H; Huang W; Zhang Y; Liu F; Xia L
    Theranostics; 2018; 8(6):1690-1705. PubMed ID: 29556350
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancing the antibacterial function of probiotic
    Bartram E; Asai M; Gabant P; Wigneshweraraj S
    Appl Environ Microbiol; 2023 Nov; 89(11):e0097523. PubMed ID: 37930328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.
    Kleta S; Nordhoff M; Tedin K; Wieler LH; Kolenda R; Oswald S; Oelschlaeger TA; Bleiss W; Schierack P
    Infect Immun; 2014 May; 82(5):1801-12. PubMed ID: 24549324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.